EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Intraoperative Dexamethasone and Mannitol on Postoperative Inflammatory Response in Totally Tubeless Percutaneous Nephrolithotomy: A Prospective, Double‐Blind, Controlled Clinical Trial

Ehsan Zemanati Yar iD, Iman Menbari Oskouie iD, Abdolreza Mohammadi iD, Mahdi Najarzadegan iD, Mohammadreza Nikoobakht iD, Roghayeh Koohi Ortakand iD, Seyed Reza Hosseini iD, Seyed Mohammad Kazem Aghamir iD

Advances in Urology · 2026-01 · 2026 (1)

DOI: 10.1155/aiu/9465166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Urology, online erschienen am 22.07.2026. Verfasst von Ehsan Zemanati Yar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Dexamethasone, a corticosteroid, reduces inflammation, while mannitol, a diuretic, improves renal blood flow and stone clearance. This study examines the impact of dexamethasone and mannitol during surgery on infection rates, pain control, and analgesic needs in totally tubeless PCNL (TTPCNL) patients.

Methods

This double‐blind, controlled clinical trial at a single center involved 121 patients undergoing TTPCNL. Participants were randomly divided into four groups: control, dexamethasone, mannitol, and dexamethasone–mannitol (DM). Postoperative outcomes included pain intensity measured using the visual analog scale (VAS) at 6 and 24 hours after tubleless PCNL. Patients with moderate‐to‐severe pain received rescue analgesia (paracetamol and ketorolac). Additional outcomes included length of hospital stay (LOS), serum interleukin‐6 (IL‐6) levels, gross hematuria, stone‐free rate (SFR), Clavien–Dindo grade (CDG), and postoperative complications, including sepsis, systemic inflammatory response syndrome (SIRS), hemoglobin decline, the need for angiography, hospital readmission, and acute kidney injury (AKI).

Results

This study included 81 male participants (66.9%), with a mean age of 50.9 ± 12.2 years. Patients treated with dexamethasone, either alone or with mannitol, showed significant reductions in postoperative SIRS ( p value < 0.001), hemoglobin drop ( p value < 0.001), hospital stay duration ( p value < 0.001), CDG ( p value < 0.001), postoperative pain ( p value < 0.001), and analgesic use ( p value = 0.015). IL‐6 levels in DM group were significantly lower compared to others ( p = 0.002). There were no significant reductions in occurrence of AKI, readmission, angiography, sepsis, and SFR.

Conclusions

The intraoperative use of dexamethasone and mannitol during TTPCNL effectively mitigated postoperative inflammatory responses. This was achieved by reducing levels of IL‐6 and decreasing the occurrence of SIRS. Additionally, patients experienced a shorter postoperative hospital stay, lower VAS pain score, lower CDG, and lower analgesic consumption. Trial Registration: Iranian Registry of Clinical Trials (IRCT): IRCT20190305042939N1

Schlagwörter

Stichwörter der Autor:innen

SIRSdexamethasoneinterleukin-6mannitolpain managementtotally tubeless percutaneous nephrolithotomy

Autor:innen und Institutionen

  • Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
  • Department of Urology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
  • Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.

ORCID-Profile: Ehsan Zemanati Yar, Iman Menbari Oskouie, Abdolreza Mohammadi, Mahdi Najarzadegan, Mohammadreza Nikoobakht, Roghayeh Koohi Ortakand, Seyed Reza Hosseini, Seyed Mohammad Kazem Aghamir

Zitieren

APA

Yar, E. Z., Oskouie, I. M., Mohammadi, A., Najarzadegan, M., Nikoobakht, M., Ortakand, R. K., Hosseini, S. R., & Aghamir, S. M. K. (2026). The Impact of Intraoperative Dexamethasone and Mannitol on Postoperative Inflammatory Response in Totally Tubeless Percutaneous Nephrolithotomy: A Prospective, Double‐Blind, Controlled Clinical Trial. Advances in Urology, 2026(1). https://doi.org/10.1155/aiu/9465166

Vancouver

Yar EZ, Oskouie IM, Mohammadi A, Najarzadegan M, Nikoobakht M, Ortakand RK, et al. The Impact of Intraoperative Dexamethasone and Mannitol on Postoperative Inflammatory Response in Totally Tubeless Percutaneous Nephrolithotomy: A Prospective, Double‐Blind, Controlled Clinical Trial. Advances in Urology. 2026;2026(1). doi:10.1155/aiu/9465166

BibTeX
@article{Yar2026,
  author = {Yar, Ehsan Zemanati and Oskouie, Iman Menbari and Mohammadi, Abdolreza and Najarzadegan, Mahdi and Nikoobakht, Mohammadreza and Ortakand, Roghayeh Koohi and Hosseini, Seyed Reza and Aghamir, Seyed Mohammad Kazem},
  title = {The Impact of Intraoperative Dexamethasone and Mannitol on Postoperative Inflammatory Response in Totally Tubeless Percutaneous Nephrolithotomy: A Prospective, Double‐Blind, Controlled Clinical Trial},
  journal = {Advances in Urology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/aiu/9465166}
}
Kostenlos starten →